As we turn the corner on An Insightful 2020, little did we know when we chose that theme for the year how apropos it would turn out to be.
My heartfelt gratitude goes out to our board, our stellar team of dedicated professionals, our partners, and our donors whose support helped us fulfill our mission – 365 days of the year. You weathered these unprecedented times alongside us. Despite the turbulent times we have navigated, we
continue to forge ahead in pursuit of the science that will lead us to discover new treatments and a cure for MacD.
In the spirit of the season of giving and gratitude, thank you for your continued support of our important mission to save sight through one of the most challenging years yet.
May 2021 be Joyful, Healthful, Peaceful, Hopeful & Kindful,
Dawn R. Prall
Founder & Executive Director
The SupportSight Foundation
The Support Sight Foundation’s (TSSF) mission is to save sight for millions of people who suffer from age-related macular degeneration (AMD) and lose their precious vision. As a 501 (c)3 public charity, our goal is to provide patient education and access to low vision resources to help individuals, families, and caregivers whose lives are severely impacted by AMD.
We place a high priority on connecting with people, their families and loved ones who live with the daily struggle of impaired vision.
TSSF funds innovative vision research projects conducted by top scientists in the field who are on a path to discover effective new tools, technology, and treatments for people with vision loss.
Millions of Americans with macular degeneration struggle to read their favorite magazine or newspaper. They also have difficulty driving, watching a movie, seeing a sunset, enjoying an art exhibition or even recognizing the faces of loved ones. Their world is out of focus.
Macular degeneration is the leading cause of vision impairment and blindness in people over 50. The statistics are astounding.
SupportSightSM Resources includes our toll free number to assist those living with AMD when they have questions and need information, outreach, and online and digital resources, referrals and access to disease-specific information, patient advocacy and clinical trials.